Bhagya Nekrakalaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bhagya Nekrakalaya has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Chandrashekar Konambi Ramaiah
3 shared publicationsK. J. Spandana
Division of Cell Biology and Molecular Genetics, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India
3 shared publicationsWilson Joel Rodrigues
3 shared publicationsA. N. Chandana
Division of Cell Biology and Molecular Genetics, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India
2 shared publicationsK. R. Chandrashekar
Yenepoya Pharmacy and Ayush Research Centre (YEN PARC), Yenepoya (Deemed to be University), Deralakatte, Mangalore, India
2 shared publicationsBoja Poojary
Department of Chemistry, Mangalore University, Mangalagangothri, India
1 shared publication
Latest Publications
- 17 October 2026
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 33 (37) , 17574-17583
Evaluation of physicochemical parameters of rubber industry wastewater and screening for its phytotoxicity and genotoxicity from Dakshina Kannada district, Karnataka, India
- 17 October 2026
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 33 (37) , 17574-17583
Evaluation of physicochemical parameters of rubber industry wastewater and screening for its phytotoxicity and genotoxicity from Dakshina Kannada district, Karnataka, India
- 24 September 2026
- Published by Springer Nature in Phytochemistry Reviews
- p. 1-41
Fangchinoline: an ingredient in traditional medicine with potent bioactivities
- 24 September 2026
- Published by Springer Nature in Phytochemistry Reviews
- p. 1-41
Fangchinoline: an ingredient in traditional medicine with potent bioactivities
- Open Access
- 10 March 2026
- Published by Elsevier in Phytomedicine Plus
- Vol. 6 (2)
Plant citronellol regulates type 1 diabetes in streptozotocin-induced diabetic rodent models
- 10 March 2026
- Published by Elsevier in Phytomedicine Plus
- Vol. 6 (2)
Open AccessPlant citronellol regulates type 1 diabetes in streptozotocin-induced diabetic rodent models
- Open Access
- 1 August 2025
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Journal of Scientific & Industrial Research
- Vol. 84 (8) , 879-889
Integrated Metabolomics and Network Pharmacology to Decipher the Antioxidant and Anti-inflammatory Potential of Gymnostachyum febrifugum (Benth) and an In Vitro Validation
Gymnostachyum febrifugum is an endemic species of the Western Ghats of India and is well-mentioned in ethnomedicine to treat fever, ulcers, cough, and metrorrhagia. The present study focuses on the GC-MS/MS analysis to identify the phytochemicals with antioxidant and anti-inflammatory properties followed by integrated metabolomics and network pharmacology approaches to determine the molecular targets of antioxidant and anti-inflammatory potential of the phytochemicals in G. febrifugum. Further, the antioxidant and anti-inflammatory activities were validated using in vitro experimental methods. A total of 10 antioxidant and anti-inflammatory metabolites were identified by GC-MS/MS analysis. Based on the network pharmacology, ALB, HSP90AA1, PPARG, SOD2, and CASP3 as antioxidant protein targets, and ALB, CD4, MMP9, HMOX1, and EGFR as anti-inflammatory protein targets were identified. Molecular docking also confirmed binding affinities of the detected phytochemicals with these protein targets. The in vitro studies validated the in-silico results on the antioxidant and anti-inflammatory activities by the G. febrifugum. The in vitro results showed the potent antioxidant activity of ethyl acetate extract of G. febrifugum with SC50 values for 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS), and hydrogen peroxide scavenging assay values of 0.17 ± 0.0 mg/mL, 0.23 ± 0.03 mg/mL and 0.110 ± 0.03 mg/mL respectively. The Ferric-Reducing Ability of Plasma (FRAP) assay showed an FRAP value of 0.2108 ± 0.01 mg GAE/mL. The antioxidant activity of gallic acid with SC50 for DPPH and ABTS was 0.0028 ± 0.10 and 0.004 ± 0.7, respectively. Similarly, the anti-inflammatory potential was confirmed with the inhibition of heat-induced protein denaturation and proteinase enzyme activity with IC50 values for 0.0410 ± 0.003 mg/mL and 0.0721 ± 0.073 mg/mL, respectively. Therefore, the study concludes that integrating in silico analysis with in vitro results validates the antioxidant and anti-inflammatory potential of G. febrifugum. This will further confirm the ethnomedicinal claim of G. febrifugum to treat fever, ulcer, cough, and snake bites. Further work on the isolation of individual phytochemicals with antioxidant and anti-inflammatory activities will be beneficial to develop suitable health-benefiting antioxidant and anti-inflammatory agents.
- 1 August 2025
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Journal of Scientific & Industrial Research
- Vol. 84 (8) , 879-889
Open AccessIntegrated Metabolomics and Network Pharmacology to Decipher the Antioxidant and Anti-inflammatory Potential of Gymnostachyum febrifugum (Benth) and an In Vitro Validation
Gymnostachyum febrifugum is an endemic species of the Western Ghats of India and is well-mentioned in ethnomedicine to treat fever, ulcers, cough, and metrorrhagia. The present study focuses on the GC-MS/MS analysis to identify the phytochemicals with antioxidant and anti-inflammatory properties followed by integrated metabolomics and network pharmacology approaches to determine the molecular targets of antioxidant and anti-inflammatory potential of the phytochemicals in G. febrifugum. Further, the antioxidant and anti-inflammatory activities were validated using in vitro experimental methods. A total of 10 antioxidant and anti-inflammatory metabolites were identified by GC-MS/MS analysis. Based on the network pharmacology, ALB, HSP90AA1, PPARG, SOD2, and CASP3 as antioxidant protein targets, and ALB, CD4, MMP9, HMOX1, and EGFR as anti-inflammatory protein targets were identified. Molecular docking also confirmed binding affinities of the detected phytochemicals with these protein targets. The in vitro studies validated the in-silico results on the antioxidant and anti-inflammatory activities by the G. febrifugum. The in vitro results showed the potent antioxidant activity of ethyl acetate extract of G. febrifugum with SC50 values for 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS), and hydrogen peroxide scavenging assay values of 0.17 ± 0.0 mg/mL, 0.23 ± 0.03 mg/mL and 0.110 ± 0.03 mg/mL respectively. The Ferric-Reducing Ability of Plasma (FRAP) assay showed an FRAP value of 0.2108 ± 0.01 mg GAE/mL. The antioxidant activity of gallic acid with SC50 for DPPH and ABTS was 0.0028 ± 0.10 and 0.004 ± 0.7, respectively. Similarly, the anti-inflammatory potential was confirmed with the inhibition of heat-induced protein denaturation and proteinase enzyme activity with IC50 values for 0.0410 ± 0.003 mg/mL and 0.0721 ± 0.073 mg/mL, respectively. Therefore, the study concludes that integrating in silico analysis with in vitro results validates the antioxidant and anti-inflammatory potential of G. febrifugum. This will further confirm the ethnomedicinal claim of G. febrifugum to treat fever, ulcer, cough, and snake bites. Further work on the isolation of individual phytochemicals with antioxidant and anti-inflammatory activities will be beneficial to develop suitable health-benefiting antioxidant and anti-inflammatory agents.
- 11 January 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 197 (5) , 2887-2909
In Vitro Cytotoxic Potential and Integrated Network Pharmacology, Molecular Docking and Molecular Dynamic Approaches to Decipher the Mechanism of Gymnostachyum febrifugum Benth., in the Treatment of Breast Cancer
Gymnostachyum febrifugum, a less-known ethnomedicinal plant from the Western Ghats of India, is used to treat various diseases and serves as an antioxidant and antibacterial herb. The present study aims to profile the cytotoxic phytochemicals in G. febrifugum roots using GC–MS/MS, in vitro confirmation of cytotoxic potential against breast cancer and an in silico study to understand the mechanism of action. Phytochemical profiling using GC–MS/MS showed the presence of eight cytotoxic molecules with lupeol in high abundance. A potent cytotoxic effect of G. febrifugum roots against breast cancer was also observed with antiproliferation, antimigration, inhibition in colony formation and death of breast cancer cells. Further, the cytotoxic potential of the plant was confirmed with the apoptosis of cells as observed in the flow cytometry. In silico network pharmacology, GO and KEGG analysis suggested the modulation of proteins of MAPK, PI3K-AKT and apoptosis pathways by lupeol to induce cytotoxicity in breast cancer. Further, dynamic simulation revealed MAPK and AKT as the major targets for lupeol. Our studies comprehensively elucidated the role of lupeol, a major phytochemical in G. febrifugum to induce cytotoxicity against breast cancer by targeting major cancer signaling pathways, providing a promising strategy and scientific basis to explore lupeol in targeted cancer therapy.
- 11 January 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 197 (5) , 2887-2909
In Vitro Cytotoxic Potential and Integrated Network Pharmacology, Molecular Docking and Molecular Dynamic Approaches to Decipher the Mechanism of Gymnostachyum febrifugum Benth., in the Treatment of Breast Cancer
Gymnostachyum febrifugum, a less-known ethnomedicinal plant from the Western Ghats of India, is used to treat various diseases and serves as an antioxidant and antibacterial herb. The present study aims to profile the cytotoxic phytochemicals in G. febrifugum roots using GC–MS/MS, in vitro confirmation of cytotoxic potential against breast cancer and an in silico study to understand the mechanism of action. Phytochemical profiling using GC–MS/MS showed the presence of eight cytotoxic molecules with lupeol in high abundance. A potent cytotoxic effect of G. febrifugum roots against breast cancer was also observed with antiproliferation, antimigration, inhibition in colony formation and death of breast cancer cells. Further, the cytotoxic potential of the plant was confirmed with the apoptosis of cells as observed in the flow cytometry. In silico network pharmacology, GO and KEGG analysis suggested the modulation of proteins of MAPK, PI3K-AKT and apoptosis pathways by lupeol to induce cytotoxicity in breast cancer. Further, dynamic simulation revealed MAPK and AKT as the major targets for lupeol. Our studies comprehensively elucidated the role of lupeol, a major phytochemical in G. febrifugum to induce cytotoxicity against breast cancer by targeting major cancer signaling pathways, providing a promising strategy and scientific basis to explore lupeol in targeted cancer therapy.
- Open Access
- 4 October 2024
- Published by Elsevier in South African Journal of Botany
- Vol. 174, 796-819
A critical review on the phytochemistry, pharmacology and toxicology of Caesalpinia pulcherrima (L.) Sw.
- 4 October 2024
- Published by Elsevier in South African Journal of Botany
- Vol. 174, 796-819
Open AccessA critical review on the phytochemistry, pharmacology and toxicology of Caesalpinia pulcherrima (L.) Sw.
- Open Access
- 7 December 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 650, 123686
Co-delivery of lapatinib and 5-fluorouracil transfersomes using transpapillary iontophoresis for breast cancer therapy
- 7 December 2023
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 650, 123686
Open AccessCo-delivery of lapatinib and 5-fluorouracil transfersomes using transpapillary iontophoresis for breast cancer therapy
- Open Access
- 1 December 2023
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 13-16
ANTICANCER POTENTIAL OF SALACIA CHINENSIS L. AND WOODFORDIA FRUTICOSA (L.) KURZ OF THE WESTERN GHATS FORESTS OF INDIA
Objective: Salacia chinensis and Woodfordia fruticosa are medicinal plants from the Western Ghats of India traditionally used in the treatment of diabetes, diarrhea and worm infections. The current study aims to evaluate the cytotoxic potential of methanolic extract of Salacia chinensis and Woodfordia fruticosa against breast and pancreatic cancers. Methods: Methanolic extract of dried leaves of Salacia chinensis and Woodfordia fruticosa were obtained by Soxhlet extraction. The cytotoxic potential of the dried extract was evaluated against human breast (MDA-MB-231) and pancreatic (PANC-1) cancers in vitro using MTT-based assay. Results: The study showed a dose-dependent cytotoxicity of Salacia chinensis and Woodfordia fruticosa leaf extracts against breast and pancreatic cancers with IC50 values of 124 μg/ml against MDA-MB-231 and 230.5 μg/ml against PANC–1 cells, respectively. Conclusion: Results indicate the presence of cytotoxic phytochemicals in Salacia chinensis and Woodfordia fruticosa. Further purification of the extract might be beneficial to isolate the anticancer phytochemical.
- 1 December 2023
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Pharmacy and Pharmaceutical Sciences
- p. 13-16
Open AccessANTICANCER POTENTIAL OF SALACIA CHINENSIS L. AND WOODFORDIA FRUTICOSA (L.) KURZ OF THE WESTERN GHATS FORESTS OF INDIA
Objective: Salacia chinensis and Woodfordia fruticosa are medicinal plants from the Western Ghats of India traditionally used in the treatment of diabetes, diarrhea and worm infections. The current study aims to evaluate the cytotoxic potential of methanolic extract of Salacia chinensis and Woodfordia fruticosa against breast and pancreatic cancers. Methods: Methanolic extract of dried leaves of Salacia chinensis and Woodfordia fruticosa were obtained by Soxhlet extraction. The cytotoxic potential of the dried extract was evaluated against human breast (MDA-MB-231) and pancreatic (PANC-1) cancers in vitro using MTT-based assay. Results: The study showed a dose-dependent cytotoxicity of Salacia chinensis and Woodfordia fruticosa leaf extracts against breast and pancreatic cancers with IC50 values of 124 μg/ml against MDA-MB-231 and 230.5 μg/ml against PANC–1 cells, respectively. Conclusion: Results indicate the presence of cytotoxic phytochemicals in Salacia chinensis and Woodfordia fruticosa. Further purification of the extract might be beneficial to isolate the anticancer phytochemical.